[PDF][PDF] A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors
CC Zielinski - Transl Lung Cancer Res, 2014 - cdn.amegroups.cn
Transl Lung Cancer Res, 2014•cdn.amegroups.cn
A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors Page 1
© Translational lung cancer research. All rights reserved. Transl Lung Cancer Res
2014;3(6):406-407 www.tlcr.org Our concept on the emergence and persistence of tumor cells
multiplying in an uncontrolled way to become a threatening accumulation of malignant cells visible
upon various detection methods has changed quite considerably during the last two decades.
Whereas tumors have been primarily thought of as an accumulation of malignant cells proliferating …
© Translational lung cancer research. All rights reserved. Transl Lung Cancer Res
2014;3(6):406-407 www.tlcr.org Our concept on the emergence and persistence of tumor cells
multiplying in an uncontrolled way to become a threatening accumulation of malignant cells visible
upon various detection methods has changed quite considerably during the last two decades.
Whereas tumors have been primarily thought of as an accumulation of malignant cells proliferating …
Abstract
A review and critical consideration of immunotherapeutical concepts in non-small cell lung cancer (NSCLC) is given. Nivolumab represents a promising option in various malignancies with more results exceeding treatment of metastatic malignant melanoma eagerly awaited.
cdn.amegroups.cn